regulatory filings

  1. K

    Glenmark's Generic Injection Set to Enter US Market in April 2026

    New Delhi, February 27 Glenmark Pharmaceuticals announced on Friday that its US-based unit is preparing to introduce a generic sodium phosphate injection in the American market.The Mumbai-based pharmaceutical company stated that its product is therapeutically equivalent to Hosira Inc.'s...
  2. H

    Bandhan Bank Secures RBI Approval for SBI Mutual Fund Acquisition

    Kolkata, February 26 The Reserve Bank of India has approved a proposal by SBI Mutual Fund to acquire an aggregate holding of up to 9.99 per cent in Bandhan Bank, according to a regulatory filing on Thursday.Bandhan Bank informed stock exchanges that the RBI, through a letter dated February 25...
  3. G

    QIP Funding Fuels Credent Global Finance's Growth Strategy

    New Delhi, February 25 NBFC firm Credent Global Finance announced on Wednesday that it has raised ₹30 crore through a Qualified Institutional Placement (QIP) to fund business growth.Institutional investors participated in the QIP, further strengthening investor confidence in Credent's evolving...
  4. D

    IDFC First Bank Discovers Rs 590 Cr Fraud Involving Haryana Government Accounts

    Mumbai, February 22 IDFC First Bank disclosed on Sunday that its employees and others had committed a fraud of Rs 590 crore involving accounts held by the Haryana government with the private sector lender.In a regulatory filing made in the early hours, IDFC First Bank said it had informed the...
  5. P

    Anupam Rasayan Acquires Jayhawk Fine Chemicals, Boosts Global Presence

    New Delhi, February 14 Anupam Rasayan India reported a 12 per cent increase in consolidated net profit to Rs 61 crore for the third quarter of the 2025-26 fiscal, driven by higher sales.The company had reported a net profit of Rs 54.21 crore in the same quarter of the previous fiscal...
  6. R

    Shriram Finance Board Expansion Following MUFG Investment

    New Delhi, February 13 MUFG has proposed appointing two directors on the Shriram Finance board as nominees of the investor, following the Japanese bank's acquisition of a 20 per cent stake.Morihiko Fuji and Shinichi Fujinami would be appointed to the board to meet the applicable "fit and...
Back
Top